Personalized TMS May Improve Outcomes for Treatment-Resistant Depression
Medical Xpress1 min read43 words
A new randomized clinical trial from investigators at Mass General Brigham's Neuroscience Institute and Department of Psychiatry suggests that using personalized brain imaging to guide transcranial magnetic stimulation (TMS) may improve outcomes for people with treatment-resistant depression. Results are published in JAMA Psychiatry.
🤖 AI-generated content — This article was automatically summarised from public RSS feeds by AutoBrief. Verify important information with the original source.